Perbedaan Diagnos Laboratorium Utama Tbk. dan Charlie Hospital Semarang Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp256 (kapitalisasi pasar 715,5 M, volume 24 jam 30,64 jt). Perbedaan utamanya: Charlie Hospital Semarang Tbk. jauh lebih besar — sekitar 2,3× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (30,64 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 715,5 M |
Volume | 963,6 rb | 30,64 jt |
Lot | 9,64 rb | 306,41 rb |
Perputaran | 217,67 jt | 7,98 M |
Harga Rata-rata | 225,89 | 260,34 |
Nilai Transaksi | 217,67 jt | 7,98 M |
Harga Ekuilibrium Indikatif | 226 | 256 |
Volume Ekuilibrium Indikatif | 1 rb | 512 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →